Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.59
Delayed Data
As of Apr 24
 -0.04 / -1.52%
Today’s Change
1.93
Today|||52-Week Range
7.85
-18.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
AssetsCash--2.6M--2.0M
 
 
 
Cash & Short Term Investments3.1M3.0M2.3M2.4M
 
 
 
 
 
 
ReceivablesReceivables--250.0K--190.8K
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses------129.9K
 
 
Other Current Assets527.0K0.00612.2K0.00
 
 
 
Current Assets3.6M3.2M2.9M2.8M
 
 
 
 
 
 
Total AssetsIntangible Assets--1.1M--252.8K
 
 
 
Other Assets1.1M1.1M1.1M252.8K
 
 
 
 
 
Total Assets4.8M4.3M4.1M3.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable--68.0K--17.0K
 
 
 
Accrued Expenses------269.7K
 
 
Other Current Liabilities--190.0K--269.7K
 
 
 
Other Liabilities--258.0K--329.7K
 
 
 
 
Total LiabilitiesOther Liabilities372.0K0.00231.1K0.00
 
 
 
Total Liabilities372.0K258.0K231.1K329.7K
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity4.4M4.1M3.8M2.7M
 
 
 
 
 
Total Shareholder Equity4.4M4.1M3.8M2.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.7M2.7M2.7M2.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.